ST
SGMO

Spot Trading’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Spot Trading’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-500
Closed -$5K – 3896
2015
Q4 		$5K Sell
500
-500
-50% -$3.85K ﹤0.01% 3409
2015
Q3 		$6K Buy
+1,000
New +$8.25K ﹤0.01% 3676

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Spot Trading's SGMO Position: Q2 2015 in Review

Spot Trading sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2015, closing a stake of 10 shares — an estimated $129 sold.

Spot Trading first reported a position in SGMO in Q1 2015 and held it in 1 quarter. The position peaked at $0 in Q1 2015. 156 funds tracked by Wall St. Rank hold SGMO as of Q2 2015.

  • Spot Trading reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2015 after selling out during the quarter.
  • Spot Trading sold 10 SANGAMO THERAPEUTICS INC shares in Q2 2015, an estimated $129.
  • Spot Trading first reported a position in SANGAMO THERAPEUTICS INC in Q1 2015 and held it in 1 quarter.
  • Spot Trading's SANGAMO THERAPEUTICS INC position peaked at $0 in Q1 2015.
  • 156 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2015.

Based on Spot Trading's 13F filing for Q2 2015, filed 11 Aug 2015.